Immunizations

A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in…
Read More...

A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store.Antonio Perez | Tribune News Service | Getty…
Read More...

Streptococcus agalactiae bacteria, responsible for vaginal and urinary tract infections and newborn infections including…
Read More...

A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody…
Read More...

A nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine's…
Read More...

Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesThe Centers for Disease Control and Prevention on…
Read More...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic…
Read More...

<!-- Name:DistributionId Value:8833187 --> <!--…
Read More...

By LAURAN NEERGAARD - AP Medical Writer WASHINGTON (AP) — The U.S. approved the…
Read More...

The U.S. Food and Drug Administration approved the first vaccine against a common respiratory virus in older…
Read More...